⚡ Medical & Pharma Updated June 2026 ✓ Active Coverage

Is the Spinal Cord Stimulator Lawsuit Legitimate? Key Legal Insights

Spinal cord stimulator lawsuits allege device malfunctions, inadequate instructions, and undisclosed risks. Learn whether these cases are legitimate and what injured patients need to know.

Category

Medical & Pharma

Coverage

2025–2026

Last Updated

June 2026

Content Type

Legal Analysis

The SCS Industry's Defect Problem: Medtronic, Abbott, Boston Scientific

Spinal cord stimulator lawsuits target all three major manufacturers (Medtronic, Abbott (formerly St. Jude Medical), and Boston Scientific) across a range of device generations and failure modes. SCS devices are among the most expensive and complex implantable devices in pain medicine, with the full device system costing $20,000-$50,000 and implantation surgery adding $30,000-$80,000 in facility and physician fees. When these devices fail, the financial and physical stakes are enormous.

Common defect theories across the SCS litigation landscape include: inadequate clinical testing before FDA approval; failure to disclose known failure rates in post-market surveillance studies; software defects causing unintended stimulation changes; hardware failures (lead fractures, connector failures, battery abnormalities) at higher-than-disclosed rates; and failure to issue timely recalls when cumulative adverse event data indicated systematic device performance problems.

FDA PMA and the 510(k) Pathway Implications

Most advanced SCS systems are approved under the FDA's Premarket Approval (PMA) pathway, the most rigorous device approval process, requiring clinical trial evidence of safety and efficacy. PMA approval does not preempt all state tort claims (under Medtronic v. Lohr and Riegel v. Consulting medical device defect attorneys can help evaluate your specific claim. Medtronic, state claims that seek to impose different requirements than the specific PMA specifications are preempted; parallel claims alleging violation of the FDA-approved specifications are not). Navigating preemption is a critical early case evaluation step in SCS litigation.

The preemption analysis means your attorney must carefully examine the specific FDA approval conditions for your device model and craft claims that parallel rather than supplement the federal requirements. This is specialized work that distinguishes experienced device defect attorneys from generalists. Related: medical device failure-to-warn comparison.

How to File a Claim or Get Help

If you believe you qualify based on the eligibility criteria outlined above, the next step is a free consultation with an experienced attorney who handles this case type. Most plaintiff-side attorneys offer no-cost initial evaluations and work on contingency, meaning you pay nothing unless your case results in a recovery. Bring any relevant documentation to your consultation: receipts, medical records, correspondence, or any evidence of the harm you experienced.

To stay current on case developments, claim deadlines, and settlement news, bookmark this page and subscribe to the LawsuitWatch newsletter. We update our coverage as new court filings, settlement announcements, and eligibility changes are made public.

Free Legal Evaluation

Do You Qualify to File a Claim?

Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.

spinal cord stimulator lawsuit Medical & Pharma 2026 Lawsuit Settlement Legal Rights

Is the Spinal Cord Stimulator Lawsuit Legitimate? Key Legal Insights: Frequently Asked Questions

Answers to the most common questions about this case and your legal options.

What are the most common spinal cord stimulator failures?

Documented failures include: lead fractures (the wire connecting the pulse generator to the spinal electrodes breaks); lead migration (the electrode moves from its original placement); battery depletion faster than labeled; software/firmware errors causing unexpected stimulation patterns; charging system failures in rechargeable units; and connector corrosion or failure causing stimulation interruption.

Is there a class action for spinal cord stimulators?

SCS litigation generally proceeds as individual product liability cases rather than a single class action, because each patient's injuries and damages are distinct. However, cases involving the same manufacturer and device model may be consolidated in an MDL for coordinated pretrial proceedings. Check PACER for active MDL proceedings involving your specific device.

Who can be sued for a defective SCS device?

Potential defendants include: the device manufacturer (primary defendant); the implanting surgeon if improper surgical technique contributed to failure; the facility where implantation occurred if inadequate procedures contributed; and potentially the distributor or sales representative if they provided inadequate training on device use and programming.

What is the typical compensation for an SCS injury?

Compensation depends on the severity and permanence of the device failure consequences. Revision surgery cases with full recovery: $50,000-$200,000. Cases with permanent worsening of the underlying pain condition: $200,000-$1,000,000+. Cases involving serious surgical complications from revision (infection, paralysis, death): potentially higher. Each case requires individual medical and economic expert analysis.

How do I know if my SCS was recalled?

Search the FDA's Medical Device Recall database (fda.gov) using your device manufacturer and model name. Also review your manufacturer's patient safety communications, Abbott, Medtronic, and Boston Scientific all maintain patient safety notification pages. Your implanting physician should have received recall notices if your device is affected.

LawsuitWatch Legal Research Team

Medical & Pharma Litigation Desk

The LawsuitWatch Legal Research Team monitors federal court PACER filings, MDL docket activity, regulatory enforcement actions, and legal settlements to deliver accurate, timely coverage of litigation affecting American consumers. Content is reviewed for factual accuracy before publication and updated as cases develop. Last reviewed: June 2026.